Biomarker Card
This biomarker card gives comprehensive information about each biomarker.
| Detailed Information | |
|---|---|
| Biomarker ID | 1996 |
| PMID | 22589488 |
| Year | 2012 |
| Biomarker | Methylation status of RAFTLIN |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Differentially Methylated in Clinical recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Clinical recurrence vs. biochemical recurrence |
| Type of Biomarker | Prognostic |
| Cohort | clinical recurrence (n = 80) versus biochemical recurrence (n = 43) |
| Senstivity | 62.7 (49.1–75.0) |
| Specificity | 64.1 (47.2–78.8) |
| AUC | 0.668 |
| Accuracy | NA |
| Level Of Significance | <0.0050 |
| Method Used | Pyrosequencing |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | RAFTLIN |